Literature DB >> 4263743

Cerebrospinal fluid choline in extrapyramidal disorders.

S M Aquilonius, B Nyström, J Schuberth, A Sundwall.   

Abstract

Cerebrospinal fluid from patients with Parkinson's disease and Huntington's chorea has been investigated with regard to the concentration of choline. In Parkinson's disease the choline concentration of lumbar spinal fluid was not different from that of a control group, nor was it related to medication, duration of illness, or severity of symptoms. A comparison between choline in ventricular cerebrospinal fluid from patients with Parkinson's disease and with intention tremor showed no significant differences. Patients with Huntington's chorea had a lower concentration of choline in lumbar spinal fluid as compared with a control group. The results are discussed in relation to the possible sources of cerebrospinal fluid choline.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4263743      PMCID： PMC494156          DOI： 10.1136/jnnp.35.5.720

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  16 in total

1.  Cholinergic and dopaminergic mechanisms in Huntington's chorea.

Authors:  S M Aquilonius; R Sjöström
Journal:  Life Sci I       Date:  1971-04-01

2.  Biochemical studies in Huntington's chorea. VI. Composition of striatal neutral lipids, phospholipids, glycolipids, fatty acids, and amino acids.

Authors:  P F Borri; W M Op den Velde; G J Hooghwinkel; G W Bruyn
Journal:  Neurology       Date:  1967-02       Impact factor: 9.910

3.  Quantitative analysis and fatty acid composition of phospholipid constituents in cerebrospinal fluid of various age groups.

Authors:  P S Sastry; H C Stancer
Journal:  Clin Chim Acta       Date:  1968-11       Impact factor: 3.786

4.  The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups.

Authors:  L Beani; C Bianchi; L Santinoceto; P Marchetti
Journal:  Int J Neuropharmacol       Date:  1968-09

5.  Gas chromatographic evaluation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain.

Authors:  L B Campbell; D J Jenden
Journal:  J Neurochem       Date:  1970-12       Impact factor: 5.372

6.  Amphetamine effect on the choline concentration of human cerebrospinal fluid.

Authors:  L E Jönsson; J Schuberth; A Sundwall
Journal:  Life Sci       Date:  1969-09-01       Impact factor: 5.037

7.  Measurement of rigidity and tremor in Parkinson's disease.

Authors:  S M Aquilonius; P Tiselius
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

8.  Choline in cerebrospinal fluid.

Authors:  M B Bowers
Journal:  Life Sci       Date:  1967-09-15       Impact factor: 5.037

9.  Cerebrospinal fluid acetylcholine in man.

Authors:  R C Duvoisin; W D Dettbarn
Journal:  Neurology       Date:  1967-11       Impact factor: 9.910

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  10 in total

1.  The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.

Authors:  S Consolo; H Ladinsky; S Bianchi; T Caraceni
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-05-16

2.  Bradycardia and second-degree AV block: an expression of the dominance of cholinergic activity in the rigid form of Huntington's disease.

Authors:  T Stober; S Sen; L Burger
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

3.  Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.

Authors:  S M Aquilonius; S A Eckernås; A Sundwall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

4.  Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.

Authors:  B V Manyam; E Giacobini; J A Colliver
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders.

Authors:  F Flentge; W M Hajonides-van Der Meulen; J P Lakke; A W Teelken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

6.  Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.

Authors:  K L Davis; L E Hollister; J Livesey; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

7.  Biochemical aspects of Huntington's chorea.

Authors:  T Caraceni; G Calderini; A Consolazione; E Riva; S Algeri; F Girotti; R Spreafico; A Branciforti; A Dall'olio; P L Morselli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

8.  Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.

Authors:  M J Welch; C H Markham; D J Jenden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

9.  Tumor metabolism and neurocognition in CNS lymphoma.

Authors:  Huimin Geng; Mazie Tsang; Lakshmipriya Subbaraj; Joseph Cleveland; Lingjing Chen; Ming Lu; Jigyasa Sharma; Daniel B Vigneron; John Kurhanewicz; Marisa LaFontaine; Tracy Luks; Bruce A Barshop; Jon Gangoiti; Javier E Villanueva-Meyer; James L Rubenstein
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 12.300

Review 10.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.